CXCL12 and cancer: In this setting, the decreased expression of CXCL-12 leads to intra-tumoral T cell accumulation, which in turn synergizes with immuno- or chemotherapy to reduce cancer cells abundance (Feig et al., 2013; Sherman et al., 2014).